Geo Capital Gestora de Recursos Ltd raised its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 5,626.7% during the fourth quarter, Holdings Channel reports. The firm owned 4,295 shares of the conglomerate’s stock after buying an additional 4,220 shares during the quarter. Danaher makes up approximately 1.3% of Geo Capital Gestora de Recursos Ltd’s portfolio, making the stock its 21st biggest position. Geo Capital Gestora de Recursos Ltd’s holdings in Danaher were worth $986,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in the stock. Heck Capital Advisors LLC purchased a new stake in shares of Danaher in the 4th quarter worth about $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher in the 4th quarter worth about $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher in the 4th quarter worth about $31,000. Teachers Insurance & Annuity Association of America purchased a new stake in shares of Danaher in the 3rd quarter worth about $39,000. Finally, Pineridge Advisors LLC grew its position in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Danaher
In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 10.90% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Research Report on Danaher
Danaher Price Performance
DHR opened at $211.63 on Friday. The company’s 50-day simple moving average is $217.46 and its two-hundred day simple moving average is $238.86. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a market capitalization of $151.26 billion, a P/E ratio of 40.08, a P/E/G ratio of 2.66 and a beta of 0.82.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the firm posted $2.09 EPS. As a group, analysts predict that Danaher Co. will post 7.63 EPS for the current year.
Danaher Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- What is a Death Cross in Stocks?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What Are Dividend Contenders? Investing in Dividend Contenders
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.